Pfizer 1Q Revenues: $25.7 billion (+77%)  1Q Earnings: $7.9 billion (+61%)  Comments: Vaccines sales were $14.9 billion in the quarter, up from $4.9 billion in 1Q21. Comirnaty revenues were approximately $32 billion. This guidance includes doses expected to be delivered in fiscal 2022 under contracts signed as of mid-April 2022. Paxlovid revenues were approximately $22 billion. This includes treatment courses expected to be delivered in fiscal 2022, primarily relating to supply contracts sign...